December 2025
1. REGIDOR PA, Angulo A, Colli E
   Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol.
   Gynecol Endocrinol. 2025;41:2458708.
   

   >> Share

   
   
2. NI MM, Yang ST, Sun JY, Wu WW, et al
   Efficacy of first-year GnRHa therapy in girls with idiopathic central precocious puberty diagnosed after age 8: a retrospective study.
   Gynecol Endocrinol. 2025;41:2500481.
   

   >> Share

   
   
3. VANNUCCINI S, La Torre F, Toscano F, Speciale AR, et al
   Medical treatment for adenomyosis: long term use of progestins.
   Gynecol Endocrinol. 2025;41:2511329.
   

   >> Share

   
   December 2024
4. COSAR A, Ozcan P, Tanoglu FB, Tok OE, et al
   Comparative effects of the antioxidant glutathione with metformin and Diane-35 on hormonal, metabolic, and inflammatory indicators in a DHEA-induced PCOS rat model.
   Gynecol Endocrinol. 2024;40:2302086.
   

   >> Share

   
   
5. HAN SJ, Kim H, Ku SY, Suh CS, et al
   Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome.
   Gynecol Endocrinol. 2024;40:2309349.
   

   >> Share

   
   
6. LA TORRE F, Vannuccini S, Toscano F, Gallucci E, et al
   Long-term treatment for endometriosis with dienogest: efficacy, side effects and tolerability.
   Gynecol Endocrinol. 2024;40:2336121.
   

   >> Share

   
   
7. REGIDOR PA, Colli E, Jakimiuk A
   The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development.
   Gynecol Endocrinol. 2024;40:2382800.
   

   >> Share

   
   December 2023
8. FARRIS M, Arisi E, Mirjalili N, Nappi RE, et al
   Attitudes of women and pharmacists on the opportunity to obtain a progestogen-only pill over the counter - Italian outcomes.
   Gynecol Endocrinol. 2023;39:2206922.
   

   >> Share

   
   
9. GENAZZANI AR, Fidecicchi T, Arduini D, Giannini A, et al
   Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice.
   Gynecol Endocrinol. 2023;39:2247093.
   

   >> Share

   
   
10. NAPPI RE, Farris M, Gallina Toschi A, Michieli R, et al
    Overcoming barriers to oral contraception in Italy an expert opinion to empower women.
    Gynecol Endocrinol. 2023;39:2254400.
    

    >> Share

    
    
11. PALACIOS S, Ayala G, Gonzalez G, Badilla-Apuy CL, et al
    Combined oral contraceptives: update recommendations of the Latin American contraceptive association.
    Gynecol Endocrinol. 2023;39:2271072.
    

    >> Share

    
    
12. QI Q, Xia Y, Luo J, Wang Y, et al
    Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial.
    Gynecol Endocrinol. 2023;39:2269281.
    

    >> Share

    
    October 2023
13. TAHARA N, Ito F, Kawamata M, Otani M, et al
    Dienogest does not augment the gene expression of adhesion molecules, MCP-1, and monocyte adherence in human endothelial cells.
    Gynecol Endocrinol. 2023;40:2270621.
    

    >> Share

    
    June 2023
14. PINGARRON SANTOFIMIA C, Poyo Torcal S, Lopez Verdu H, Henriquez Linares A, et al
    Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2023;39:2227277.
    

    >> Share

    
    May 2023
15. BOUNOUS VE, Actis S, Rosso R, Giorgi M, et al
    No-daily hormonal contraception today: general overview and application in specific clinical settings.
    Gynecol Endocrinol. 2023;39:2214626.
    

    >> Share

    
    
16. JI L, Jin L, Shao MJ, Hu M, et al
    Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.
    Gynecol Endocrinol. 2023;39:2208667.
    

    >> Share

    
    March 2023
17. NAPPI RE, Tiranini L, Bosoni D, Cucinella L, et al
    Women's attitudes about combined hormonal contraception (CHC) - induced menstrual bleeding changes - influence of personality traits in an Italian clinical sample.
    Gynecol Endocrinol. 2023 Mar 14:2189971. doi: 10.1080/09513590.2023.2189971.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share